20.59
-1.15(-5.29%)
Currency In USD
| Previous Close | 21.74 |
| Open | 21.83 |
| Day High | 21.85 |
| Day Low | 20.57 |
| 52-Week High | 27.64 |
| 52-Week Low | 16 |
| Volume | 210,033 |
| Average Volume | 647,740 |
| Market Cap | 925.16M |
| PE | -7.49 |
| EPS | -2.75 |
| Moving Average 50 Days | 25.04 |
| Moving Average 200 Days | 24.56 |
| Change | -1.15 |
If you invested $1000 in Pacira BioSciences, Inc. (PCRX) 10 years ago, it would be worth $419.18 as of October 27, 2025 at a share price of $20.59. Whereas If you bought $1000 worth of Pacira BioSciences, Inc. (PCRX) shares 5 years ago, it would be worth $390.7 as of October 27, 2025 at a share price of $20.59.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Pacira BioSciences Notified of Abbreviated New Drug Application Filing from Qilu Pharmaceutical (Hainan) Co., Ltd. for EXPAREL®
GlobeNewswire Inc.
3 hours ago
BRISBANE, Calif., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients today reported it has received a
Pacira BioSciences to Present New Data from Three Real-World Studies with EXPAREL®
GlobeNewswire Inc.
Oct 23, 2025 12:00 PM GMT
-- Findings Presented at AMCP Nexus 2025 Annual Meeting -- BRISBANE, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the li
Pacira BioSciences Notified of Abbreviated New Drug Application Filing from The WhiteOak Group for EXPAREL®
GlobeNewswire Inc.
Oct 21, 2025 12:30 PM GMT
BRISBANE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients today reported it has received a